Citadel Advisors’s Elanco Animal Health ELAN Stock Holding History

Citadel Advisors’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.91M	Buy	80,000 +700	+0.9%	+$17.1K	﹤0.01%	6146
2025 Q4	$1.79M	Buy	79,300 +3,700	+5%	+$80.5K	﹤0.01%	6147
2025 Q3	$1.52M	Buy	75,600 +12,100	+19%	+$203K	﹤0.01%	6642
2025 Q2	$907K	Sell	63,500 -29,500	-32%	-$345K	﹤0.01%	7328
2025 Q1	$977K	Sell	93,000 -11,500	-11%	-$130K	﹤0.01%	7012
2024 Q4	$1.27M	Buy	104,500 +23,700	+29%	+$310K	﹤0.01%	6547
2024 Q3	$1.19M	Buy	80,800 +5,400	+7%	+$75.2K	﹤0.01%	6520
2024 Q2	$1.09M	Buy	75,400 +9,500	+14%	+$152K	﹤0.01%	6418
2024 Q1	$1.07M	Sell	65,900 -47,700	-42%	-$746K	﹤0.01%	6773
2023 Q4	$1.69M	Buy	113,600 +28,500	+33%	+$323K	﹤0.01%	5669
2023 Q3	$957K	Sell	85,100 -158,600	-65%	-$1.84M	﹤0.01%	6642
2023 Q2	$2.45M	Buy	243,700 +27,400	+13%	+$254K	﹤0.01%	4804
2023 Q1	$2.03M	Sell	216,300 -18,300	-8%	-$216K	﹤0.01%	5333
2022 Q4	$2.87M	Sell	234,600 -59,900	-20%	-$747K	﹤0.01%	4827
2022 Q3	$3.65M	Buy	294,500 +204,400	+227%	+$3.57M	﹤0.01%	4419
2022 Q2	$1.77M	Sell	90,100 -479,200	-84%	-$11.3M	﹤0.01%	5800
2022 Q1	$14.9M	Buy	569,300 +249,500	+78%	+$6.64M	﹤0.01%	2383
2021 Q4	$9.08M	Buy	319,800 +205,300	+179%	+$6.39M	﹤0.01%	3236
2021 Q3	$3.65M	Sell	114,500 -540,400	-83%	-$18.1M	﹤0.01%	4935
2021 Q2	$22.7M	Buy	654,900 +426,700	+187%	+$14.1M	0.01%	1928
2021 Q1	$6.72M	Sell	228,200 -850,700	-79%	-$26.2M	﹤0.01%	3666
2020 Q4	$33.1M	Buy	1,078,900 +1,004,200	+1,344%	+$30.6M	0.01%	1301
2020 Q3	$2.09M	Buy	74,700 +1,800	+2%	+$45.6K	﹤0.01%	4634
2020 Q2	$1.56M	Sell	72,900 -14,500	-17%	-$320K	﹤0.01%	4997
2020 Q1	$1.96M	Buy	87,400 +45,000	+106%	+$1.23M	﹤0.01%	4176
2019 Q4	$1.25M	Buy	42,400 +14,600	+53%	+$397K	﹤0.01%	5203
2019 Q3	$739K	Sell	27,800 -1,700	-6%	-$51K	﹤0.01%	6101
2019 Q2	$997K	Sell	29,500 -131,800	-82%	-$4.28M	﹤0.01%	5700
2019 Q1	$5.17M	Buy	+161,300	New	+$4.96M	﹤0.01%	2957

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Citadel Advisors's ELAN Position: Q1 2026 in Review

Citadel Advisors increased its Elanco Animal Health (ELAN) stake by 19% in Q1 2026, buying an estimated $16.8M and bringing the position to 4,387,127 shares worth $105M. The position accounts for 0.02% of the portfolio, ranked #774.

Citadel Advisors first reported a position in ELAN in Q3 2018 and has held it in 30 quarters since. The position peaked at $251M in Q1 2019. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

Citadel Advisors held 4,387,127 shares of Elanco Animal Health worth $105M as of Q1 2026.
Citadel Advisors bought 689,001 Elanco Animal Health shares in Q1 2026, an estimated $16.8M.
Elanco Animal Health made up 0.02% of Citadel Advisors's portfolio in Q1 2026, its #774 holding.
Citadel Advisors first reported a position in Elanco Animal Health in Q3 2018 and has held it in 30 quarters since.
Citadel Advisors's Elanco Animal Health position peaked at $251M in Q1 2019.
516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.